Photo of Jennifer F. Tseng,  MD, MPH

Jennifer F. Tseng, MD, MPH

Beth Israel Deaconess Medical Center

Beth Israel Deaconess Medical Center
Phone: (617) 667-3746
Fax: (617) 667-2792

Jennifer F. Tseng, MD, MPH

Beth Israel Deaconess Medical Center


  • Associate Professor, Surgery, Harvard Medical School
  • Chief, Division of Surgical Oncology, Surgery, Beth Israel Deaconess Medical Center



  • Member, Clinical Science Coordinating Committee

Research Abstract

The overall focus of my research is predicting risk for hepatopancreaticobiliary (HPB) and upper GI malignancy and related diseases, as well as assessing the risks and benefits of various modalities employed in their treatment. To achieve that end, I have pursued several complementary avenues of investigation including (1) health services research, including large administrative databases, registries, and institutional databases; (2) biobanking and biomarker discovery for pancreatic malignancy; and (3) decision analysis and decision modeling.


Powered by Harvard Catalyst
  • Tabatabaie O, Kasumova GG, Kent TS, Eskander MF, Fadayomi AB, Ng SC, Critchlow JF, Tawa NE, Tseng JF. Upper extremity deep venous thrombosis after port insertion: What are the risk factors? Surgery 2017. PubMed
  • Kasumova GG, Eskander MF, de Geus SWL, Neto MM, Tabatabaie O, Ng SC, Miksad RA, Mahadevan A, Rodrigue JR, Tseng JF. Regional variation in the treatment of pancreatic adenocarcinoma: Decreasing disparities with multimodality therapy. Surgery 2017. PubMed
  • Mizrahi M, Tseng JF, Wong D, Tung N, Eskander MF, Berzin TM, Pleskow DK, Sawhney MS. Chronic Pancreatitis-Like Change in BRCA2 Mutation Carriers. Pancreas 2017. PubMed
  • de Geus SW, Eskander MF, Bliss LA, Kasumova GG, Ng SC, Callery MP, Tseng JF. Neoadjuvant therapy versus upfront surgery for resected pancreatic adenocarcinoma: A nationwide propensity score matched analysis. Surgery 2017; 161:592-601. PubMed
  • Tabatabaie O, Kasumova GG, Eskander MF, Critchlow JF, Tawa NE, Tseng JF. Totally Implantable Venous Access Devices: A Review of Complications and Management Strategies. Am J Clin Oncol 2017; 40:94-105. PubMed
  • Kasumova GG, Tabatabaie O, Eskander MF, Tadikonda A, Ng SC, Tseng JF. National Rise of Primary Pancreatic Carcinoid Tumors: Comparison to Functional and Nonfunctional Pancreatic Neuroendocrine Tumors. J Am Coll Surg 2016. PubMed
  • Kasumova GG, Conway WC, Tseng JF. The Role of Venous and Arterial Resection in Pancreatic Cancer Surgery. Ann Surg Oncol 2016. PubMed
  • Eskander MF, de Geus SW, Kasumova GG, Ng SC, Al-Refaie W, Ayata G, Tseng JF. Evolution and impact of lymph node dissection during pancreaticoduodenectomy for pancreatic cancer. Surgery 2016. PubMed
  • Eskander MF, Bliss LA, McCarthy EP, de Geus SW, Chau Ng S, Nagle D, Rodrigue JR, Tseng JF. Massachusetts Healthcare Reform and Trends in Emergent Colon Resection. Dis Colon Rectum 2016; 59:1063-1072. PubMed
  • Eskander MF, Schapira EF, Bliss LA, Burish NM, Tadikonda A, Ng SC, Tseng JF. Keeping it in the family: the impact of marital status and next of kin on cancer treatment and survival. Am J Surg 2016; 212:691-699. PubMed
  • Kasumova GG, Eskander MF, Kent TS, Ng SC, Moser AJ, Ahmed M, Pleskow DK, Callery MP, Tseng JF. Hemorrhage after pancreaticoduodenectomy: does timing matter? 2016; 18:861-869. PubMed
  • Kasumova GG, Miksad RA, Tseng JF. Cutting Through Confusion: Multimodality Therapy in Borderline Resectable and Locally Advanced Pancreatic Cancer. J Oncol Pract 2016; 12:924-925. PubMed
  • Klompmaker S, van Zoggel D, Watkins AA, Eskander MF, Tseng JF, Besselink MG, Moser AJ. Nationwide Evaluation of Patient Selection for Minimally Invasive Distal Pancreatectomy Using American College of Surgeons' National Quality Improvement Program. Ann Surg 2016. PubMed
  • Bliss LA, Eskander MF, Kent TS, Watkins AA, de Geus SW, Storino A, Ng SC, Callery MP, Moser AJ, Tseng JF. Early surgical bypass versus endoscopic stent placement in pancreatic cancer. 2016; 18:671-7. PubMed
  • Peters ML, Tseng JF, Miksad RA. Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment. Clin Ther 2016. PubMed
  • Eskander MF, Bliss LA, Tseng JF. Pancreatic adenocarcinoma. Curr Probl Surg 2016; 53:107-54. PubMed
  • Bliss LA, Maguire LH, Chau Z, Yang CJ, Nagle DA, Chan AT, Tseng JF. Readmission After Resections of the Colon and Rectum: Predictors of a Costly and Common Outcome. Dis Colon Rectum 2015; 58:1164-73. PubMed
  • de Geus SW, Bliss LA, Eskander MF, Ng SC, Vahrmeijer AL, Mahadevan A, Kent TS, Moser AJ, Callery MP, Bonsing BA, Tseng JF. A Tale of Two Cities: Reconsidering Adjuvant Radiation in Pancreatic Cancer Care. J Gastrointest Surg 2015. PubMed
  • Bliss LA, Yang CJ, Eskander MF, de Geus SW, Callery MP, Kent TS, Moser AJ, Freedman SD, Tseng JF. Surgical management of chronic pancreatitis: current utilization in the United States. 2015; 17:804-10. PubMed
  • Mahadevan A, Dagoglu N, Mancias J, Raven K, Khwaja K, Tseng JF, Ng K, Enzinger P, Miksad R, Bullock A, Evenson A. Stereotactic Body Radiotherapy (SBRT) for Intrahepatic and Hilar Cholangiocarcinoma. J Cancer 2015; 6:1099-104. PubMed
  • Mahadevan A, Dagoglu N, Tseng JF, Khawaja K, Evenson A. Therapeutic Potential of Adjuvant Stereotactic Body Radiotherapy for Gallbladder Cancer. Cureus 2015; 7:e299. PubMed
  • Bliss LA, Yang CJ, Chau Z, Ng SC, McFadden DW, Kent TS, Moser AJ, Callery MP, Tseng JF. Patient selection and the volume effect in pancreatic surgery: unequal benefits? 2014. PubMed
  • Bliss LA, Witkowski ER, Yang CJ, Tseng JF. Outcomes in operative management of pancreatic cancer. J Surg Oncol 2014; 110:592-8. PubMed
  • Yang CJ, Bliss LA, Schapira EF, Freedman SD, Ng SC, Windsor JA, Tseng JF. Systematic review of early surgery for chronic pancreatitis: impact on pain, pancreatic function, and re-intervention. J Gastrointest Surg 2014; 18:1863-9. PubMed
  • Chau Z, West JK, Zhou Z, McDade T, Smith JK, Ng SC, Kent TS, Callery MP, Moser AJ, Tseng JF. Rankings versus reality in pancreatic cancer surgery: a real-world comparison. 2014. PubMed
  • Arous EJ, McDade TP, Smith JK, Ng SC, Sullivan ME, Zottola RJ, Ranauro PJ, Shah SA, Whalen GF, Tseng JF. Electronic medical record: research tool for pancreatic cancer? J Surg Res 2014; 187:466-70. PubMed
  • Smith JK, Ng SC, Zhou Z, Carroll JE, McDade TP, Shah SA, Tseng JF. Does increasing insurance improve outcomes for US cancer patients? J Surg Res 2013; 185:15-20. PubMed
  • Cetin V, Piperdi B, Bathini V, Walsh WV, Yunus S, Tseng JF, Whalen GF, Wassef WY, Kadish SP, Fitzgerald TJ, Mikule C, Wang Y, Grossman SR. A Phase II Trial of Cetuximab, Gemcitabine, 5-Fluorouracil, and Radiation Therapy in Locally Advanced Nonmetastatic Pancreatic Adenocarcinoma. Gastrointest Cancer Res 2013; 6:S2-9. PubMed
  • Ragulin-Coyne E, Witkowski ER, Chau Z, Ng SC, Santry HP, Callery MP, Shah SA, Tseng JF. Is routine intraoperative cholangiogram necessary in the twenty-first century? A national view. J Gastrointest Surg 2013; 17:434-42. PubMed
  • Witkowski ER, Smith JK, Tseng JF. Outcomes following resection of pancreatic cancer. J Surg Oncol 2012. PubMed
  • Tseng JF. Proceed with caution: vascular resection at pancreaticoduodenectomy. Ann Surg Oncol 2012. PubMed
  • Ragulin-Coyne E, Carroll JE, Smith JK, Witkowski ER, Ng SC, Shah SA, Zhou Z, Tseng JF. Perioperative mortality after pancreatectomy: a risk score to aid decision-making. Surgery 2012. PubMed
  • Cooley EK, McPhee JT, Simons JP, Sweeney WB, Tseng JF, Alavi K. Colorectal neoplasia screening before age 50? Current epidemiologic trends in the United States: agency for healthcare research and quality data. Dis Colon Rectum 2012; 55:e333. PubMed
  • Dudeja V, Habermann EB, Abraham A, Zhong W, Parsons HM, Tseng JF, Al-Refaie WB. Is there a role for surgery with adequate nodal evaluation alone in gastric adenocarcinoma? J Gastrointest Surg 2012; 16:238-46; discussion 246-7. PubMed
  • Witkowski ER, Smith JK, Ragulin-Coyne E, Ng SC, Shah SA, Tseng JF. Is it worth looking? Abdominal imaging after pancreatic cancer resection: a national study. J Gastrointest Surg 2012; 16:121-8. PubMed
  • Burr AT, Li Y, Tseng JF, Saidi RF, Bozorgzadeh A, Shah SA. Survival after liver transplantation using hepatitis C virus-positive donor allografts: case-controlled analysis of the UNOS database. World J Surg 2011; 35:1590-5. PubMed